Vietnam Biomanufacturing Industry | Opportunities & Forecast to 2020
Market Entry - Biomanufacturing Market in Vietnam: Analysis of Growth, Trends and Progress (2016 - 2021)

PUBLISHED

DEC 2017

Market Entry - Biomanufacturing Market in Vietnam: Analysis of Growth, Trends and Progress (2016 - 2021)

Purchase Report

About the Market

Biologic-baseddrugs are an increasingly important part of product growth strategies for pharmaceutical and biopharmaceutical companies. Biopharmaceutical products have rapidly taken over pharmaceutical company revenues, with sales of the top six antibody products viz., Humira, Remicade, Enbrel, Rituxan, Avastin, Herceptin, at just over USD 51 billion in 2015. 77% of over 900 biopharmaceutical products are produced in mammalian cell culture systems in the United States and Europe. In terms of production capacity, North America holds the greatest at 52%, followed by Europe and Asia. Due to government incentives in tax reforms, favorable locations with mature pipelines, and the ability to manage complex global supply chains, Asia has significant growth capacity. Samsung, Bristol-Myers Squibb, and Novartis are some of the key players in the market.

About the Geography

Vietnam is a communist state located in the South China Sea bordered by China, Myanmar, and Thailand. It is the largest recipient of FDI in Asia after China and India. Earlier it used to rely on traditional industries only, but in the past few years, the government has done very well to attract huge foreign investments into the country.

The country is rapidly developing into a manufacturing hub due to its stable economy, young and cheap workforce, and socio-political stability. The government is committed to liberalizing the economy and introduce reforms to create an atmosphere of the free market. Samsung and LG have partnered with the government to manufacture everything starting from smartphones to ships. Vietnam’s FDI inflows are now being directed towards real estate, tourism, and heavy industry. Major investors are South Korea, Malaysia, and the UK. The government has set up new SEZ and FTZ and introduced tax benefits to attract foreign investments. Vietnam must work on its financial reforms and curb corruption to reach its potential to beat its Asian counterparts in attracting foreign investment. Also, Vietnam is a member of ASEAN and WTO and is committed to fair trade.

 

Component Name

Value

GDP (USD billion)

194

GDP Annual Growth Rate

6.4

GDP Per Capita

1685

Unemployment Rate

2.06

Wages

217.2

Inflation Rate

3.34

Consumer Price Index (CPI)

103

Interest Rate

6.5

Balance of Trade (USD billion)

-0.1

Manufacturing PMI (Index Points)

(52.9

Ease of Doing Business

90

Competitiveness Rank

60

Corruption Rank

112

Consumer Confidence

145

Consumer Spending (USD billion)

127.74

Corporate Tax Rate

22

Sales Tax Rate

10

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Biomanufacturing Market (USD millions)

                4.1 Biopharmaceuticals

                4.2 Industrial Enzymes

                4.3 Human Tissues

                4.4 Replacement Organs

                4.5 Biofuels

                4.6 Green Chemicals & products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Purchase Report

Our Clients Include View All

Looking to Customize Report?